Hemophilia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Excitement Builds Around Gene Therapy Cures For Hemophilia - Forbes



Forbes
 
Excitement Builds Around Gene Therapy Cures For Hemophilia 
Forbes
The New England Journal headline ? which would have seemed fantasy just a few years ago ? is a harbinger of a revolution in hemophilia treatment. A new drug, from Roche, could transform the way many patients are treated. But it's being followed by gene ...
Another Gene Therapy Breakthrough Against Hemophilia WebMD
First Successful Gene Therapy for Hemophilia A MedPage Today
'Promise of a Cure': Gene Therapy for Hemophilia A Medscape
BioPharma Dive  -Philly.com  -Healio 
all 14 news articles » 


A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients - Yahoo News



Yahoo News
 
A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients 
Yahoo News
Patients diagnosed with hemophilia B suffer a lifetime of treatment, but that could change based on recently reported data from an early stage trial Pfizer (NYSE: PFE) and Spark Therapeutics (NASDAQ: ONCE) are conducting. The two companies are teamed ...

and more » 


BioMarin's gene therapy reduces bleeding in hemophilia patients - STAT



STAT
 
BioMarin's gene therapy reduces bleeding in hemophilia patients 
STAT
With the newly approved Hemlibra, Roche has already put the hemophilia A businesses of Shire and Bioverativ at risk. BioMarin might do the same to Roche.

and more » 


1-year data set Spark/Pfizer on track with hemophilia B gene therapy ... - FierceBiotech



FierceBiotech
 
1-year data set Spark/Pfizer on track with hemophilia B gene therapy ... 
FierceBiotech
Patients with hemophilia B have seen their symptoms controlled for up to a year with a single dose of a gene therapy developed by Spark Therapeutics, almost entirely eliminating the need for treatment with clotting factors. Over the course of the ...
Gene therapy makes a big advance treating hemophilia B blood disorder Washington Post
Spark, Pfizer pass another milestone with impressive results treating ... Endpoints News
Spark gene therapy nearly eliminates bleeding episodes in hemophilia B patients STAT
Genetic Engineering & Biotechnology News  -WebMD  -EurekAlert (press release)  -The New England Journal of Medicine 
all 37 news articles » 


Prophylactic Tx Stems Bleeds in Hemophilia A with Inhibitors - MedPage Today



Prophylactic Tx Stems Bleeds in Hemophilia A with Inhibitors 
MedPage Today
In November 2017, the FDA approved emicizumab for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A with factor VIII inhibitors. Approval was based on data from HAVEN 1, an ...

 


Emicizumab 'Life-Changing' for Hemophilia A With Inhibitors - Medscape



Medscape
 
Emicizumab 'Life-Changing' for Hemophilia A With Inhibitors 
Medscape
Dr Young explained that patients with hemophilia A suffer from debilitating bleeding events, especially in the joints, which cause significant pain in the short term, as well as long-term joint disease. Treating the patients with frequent intravenous ...

 


Inflammatory factors linked to inhibition of factor VIII gene therapy in ... - Medical Xpress



Medical Xpress
 
Inflammatory factors linked to inhibition of factor VIII gene therapy in ... 
Medical Xpress
As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from the transferred FVIII gene ...
Gene therapy could be 'ideal cure' for hemophilia B | Genetic ... Genetic Literacy Project
Gene therapy shows promise against hemophilia CTV News
Gene therapy shows promising effect against blood clots, study states News-Medical.net

all 7 news articles » 


Emicizumab-kxwh prophylaxis reduces bleeds among children with ... - Healio



Emicizumab-kxwh prophylaxis reduces bleeds among children with ... 
Healio
ATLANTA ? Emicizumab-kxwh prophylaxis prevented or considerably reduced bleeds among pediatric patients with hemophilia A with inhibitors, according to results of a phase 3 study presented at the ASH Annual Meeting and Exposition.Emicizumab-kxwh ...
New Therapies Improve Outlook for Bleeding and Clotting Disorders ... Markets Insider

all 2 news articles » 


Study Shows Weekly Prophylactic Treatment with ELOCTATE ... - Business Wire (press release)



Study Shows Weekly Prophylactic Treatment with ELOCTATE ... 
Business Wire (press release)
Study Shows Weekly Prophylactic Treatment with ELOCTATEŽ Resulted in Bleed Protection and Target Joint Resolution in People with Hemophilia A.

and more » 


Roche hemophilia drug wins FDA nod, with a warning - Reuters



Reuters
 
Roche hemophilia drug wins FDA nod, with a warning 
Reuters
?Today's approval of Hemlibra represents an important advancement for people with hemophilia A with inhibitors, who have struggled to manage their bleeding disorder and haven't had a new medicine in nearly 20 years,? said Sandra Horning, Roche's chief ...
FDA Clears First-in-Class Emicizumab for Hemophilia A Medscape
FDA approves first new hemophilia treatment in nearly 20 years New York Post
FDA approves new treatment to prevent bleeding in certain patients with hemophilia A FDA.gov
National Hemophilia Foundation  -Business Wire  -MPR 
all 72 news articles »